Synaptogenix Inc (SNPX)

[runncoach]

I'm in the same camp. I think if we repeat results and a company was interested in buying us out, I think we're a 1.5 billion dollar company at that point. Now that isn't the same thing exactly as what the share price would be with those results and without a suitor or if we chose to go it alone and finance additional trials. I don't know what the market cap is under that condition. Could take awhile but keep in mind if bryostatin really re-grows synapses, fragile X and other indications will follow.

As for percentages, I'm never one to say anything is a guaranteed no matter how convincing the science so I just say I think its more likely than not that they can repeat the last trial. They just met too many data points with the testing for it to be explained away even though the numbers were small. The more data and the more patients we treat, the more success bryostatin has shown. It's convinced me.